Duke University Medical Center, Durham, North Carolina, USA.
Catheter Cardiovasc Interv. 2012 Mar 1;79(4):603-12. doi: 10.1002/ccd.23269. Epub 2011 Dec 12.
This study sought to assess the benefits of a coronary chronic total occlusion CTO recanalization after adjusting for the case-mix and the propensity to undergo the CTO intervention in a population of patients with stable coronary artery disease.
The benefits of percutaneous recanalization of CTO are disputed.
In 1,602 patients with a least one CTO and treated by percutaneous coronary intervention (PCI), we derived a propensity score to undergo a CTO recanalization by comparing the characteristics of patients who did (n = 346) and did not (n = 1,256) undergo a CTO PCI attempt. Among the patients who underwent a CTO PCI attempt, we identified the angiographic predictors of failure. The primary analysis was ultimately performed by looking at the association between the outcome of the CTO recanalization and the survival free of death and cardiovascular rehospitalizations. Sensitivity analyses were performed by adjusting for the propensity to undergo a CTO recanalization, for the anatomical predictors of failure, and for the extent of coronary artery revascularization achieved.
A successful CTO recanalization was not significantly associated with survival free of death and cardiovascular rehospitalization (HR = 0.90, 95% CI 0.64-1.25). Even more conservative hazards ratio point estimates were obtained with the sensitivity analyses.
Successful percutaneous CTO recanalization is not associated with survival free of death and cardiovascular hospitalizations in a contemporary population of patients with symptomatic coronary artery disease.
本研究旨在评估调整病例组合和 CTO 干预倾向后,稳定型冠心病患者行冠状动脉慢性完全闭塞(CTO)再通的获益。
经皮 CTO 再通的获益存在争议。
在至少存在一条 CTO 且接受经皮冠状动脉介入治疗(PCI)的 1602 例患者中,我们通过比较行 CTO PCI 尝试的患者(n=346)和未行 CTO PCI 尝试的患者(n=1256)的特征,得出行 CTO 再通的倾向评分。在接受 CTO PCI 尝试的患者中,我们确定了 CTO 再通失败的血管造影预测因素。主要分析是通过观察 CTO 再通的结果与无死亡和心血管再住院的生存之间的关联来进行的。敏感性分析是通过调整 CTO 再通的倾向、失败的解剖预测因素和实现的冠状动脉血运重建程度来进行的。
成功的 CTO 再通与无死亡和心血管再住院的生存无关(HR=0.90,95%CI 0.64-1.25)。在敏感性分析中,甚至得到了更保守的危险比点估计值。
在当代有症状的冠心病患者人群中,经皮 CTO 再通成功与无死亡和心血管住院无关。